ENZAMIDE 80MG

Enzamide 80mg capsules contain the active ingredient Enzalutamide. This antineoplastic medication falls under the category of androgen receptor inhibitors. It is utilized in treating advanced prostate cancer in patients who do not respond to surgical or hormonal therapies.

These capsules should not be taken if you have an allergy to any of their components. Throughout the treatment, your physician may periodically conduct Prostate-specific antigen (PSA) tests. This blood test assesses the PSA level, a protein produced by the prostate gland that may be elevated in men with prostate cancer. Monitoring PSA levels can provide insights into disease progression and treatment efficacy. Additional tests may include liver function assessments and a complete blood count (CBC) to avert serious complications.

This medication has the potential to induce seizures; therefore, patients with a seizure history should exercise caution when using it. It is advisable to avoid grapefruit and grapefruit juice while on this medication, as they can elevate the drug’s levels in the body. This drug is contraindicated during pregnancy due to its potential harm to the unborn child and its impact on fertility. Inform your doctor of any fertility concerns prior to commencing treatment with this medication. Before starting this treatment, notify your healthcare provider if you are pregnant or planning to conceive. Both men and women are advised to adhere to effective contraceptive methods during treatment and for three months following the final dose of Enzamide 80mg capsules.